Patent ID: 8785403
Filing Date: 2014-07-22
Classification: A61K,A61P,C07H

Abstract:
1. A pharmaceutical composition comprising (i) a compound of Formula (I): Ring A is wherein R Ring B is wherein R X is a carbon atom; and Y is —(CH or a pharmaceutically acceptable salt thereof; (ii) an antidiabetic agent selected from the group consisting of insulin, an insulin secretagogue, an insulin sensitizer, a biguanide compound, a sulfonylurea compound, an α-glucosidase inhibitor, a PPARγ agonist, a PPARα/γ dual agonist, a dipeptidyl peptidase IV inhibitor, a mitiglinide compound, a nateglinide compound, a glucagon-like peptide-1, a PTP1B inhibitor, a glycogen phosphorylase inhibitor, a RXR modulator, and a glucose 6-phosphatase inhibitor; and (iii) a pharmaceutically acceptable carrier.